NGM Bio
NGM Bio is a clinical stage biopharmaceutical company that develops biologic drugs for the treatment of cardio-metabolic and liver disease.
Business Model:
Revenue: $58.1M
Employees: 201-500
Industries / Tags:
Detailed NGM Bio Information
Geographic Data
Address: 333 Oyster Point Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$125M
Raised Total:$345M
Social
Metrics
2,504,171Website Global Rank
7,194Website Monthly Traffic
Twitter Followers
Description
NGM Bio is a clinical stage biopharmaceutical company that develops biologic drugs for the treatment of cardio-metabolic and liver disease.
Contact Phone:
+16502435555
Contact Email:
NGM Bio went public on 4/4/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/4/2019
IPO Valuation:
$1B
Ticker Symbol:
NGM
IPO Price:
$16/share
Amount Raised:
$107M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
